Publications by authors named "Divina Glah"

Claim this Profile
T
The Long-Term Cost-Effectiveness of Oral Semaglutide Versus Lower-Cost Liraglutide in the UK.
Mohamed Elnaggar, Joana Nunes Mansinho, Samuel J P Malkin, Joseph Whitaker, Barnaby Hunt, Divina Glah

Diabetes Ther· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the Cost-Effectiveness of Once-Weekly Semaglutide 1 mg Versus Empagliflozin 25 mg for Treatment of Patients with Type 2 Diabetes in the UK Setting.
Matthew Capehorn, Nino Hallén, James Baker-Knight, Divina Glah, Barnaby Hunt

Diabetes Ther· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Systematic Literature Review and Network Meta-Analysis Comparing Once-Weekly Semaglutide with Other GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Previously Receiving 1-2 Oral Anti-Diabetic Drugs.
Michal Witkowski, Lars Wilkinson, Neil Webb, Alan Weids, Divina Glah

Diabetes Ther· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Systematic Literature Review and Network Meta-Analysis Comparing Once-Weekly Semaglutide with Other GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Previously Receiving Basal Insulin.
Michal Witkowski, Lars Wilkinson, Neil Webb, Alan Weids, Divina Glah

Diabetes Ther· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of liraglutide versus lixisenatide as add-on therapies to basal insulin in type 2 diabetes.
Åsa Ericsson, Divina Glah, Maria Lorenzi, Jeroen P Jansen, Adam Fridhammar

PLoS One· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling the Long-Term Cost-Effectiveness of IDegLira in Patients with Type 2 Diabetes Who are Failing To Meet Glycemic Targets on Basal Insulin Alone in The Netherlands.
Barnaby Hunt, Divina Glah, Maarten van der Vliet

Diabetes Ther· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perceptions of general practitioners on initiation and intensification of type 2 diabetes injectable therapies. A quantitative study in the United Kingdom.
Daniel Sterzi, Sébastien Auziere, Divina Glah, Marie Markert Jensen

Prim Care Diabetes· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost Effectiveness of IDegLira vs. Alternative Basal Insulin Intensification Therapies in Patients with Type 2 Diabetes Mellitus Uncontrolled on Basal Insulin in a UK Setting.
Melanie J Davies, Divina Glah, Barrie Chubb, Gerasimos Konidaris, Phil McEwan

Pharmacoeconomics· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resource use and outcomes associated with initiation of injectable therapies for patients with type 2 diabetes mellitus.
Richard Brice, Sharon Shelley, Pankaj Chaturvedi, Divina Glah, Donna Ashley

Drugs Context· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digestive Disease Week 2009. Turning science into medicine: Part 1.
Divina R Glah

IDrugs· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digestive Disease Week 2009. Turning science into medicine: Part 2.
Divina R Glah

IDrugs· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BioPartnering Europe--16th annual conference.
Divina Glah, Jonathan Bright

IDrugs· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deals landscape: notable deals in the pharmaceutical industry in the third quarter of 2008.
Divina Glah, Steven Tear

IDrugs· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
American Diabetes Association--68th Scientific Sessions. Results for ACCORD, ADVANCE and other clinical trials.
Divina Glah

IDrugs· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
American Diabetes Association--68th Scientific Sessions. Preclinical and early clinical data with promising agents.
Divina Glah

IDrugs· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
American Diabetes Association--68th Scientific Sessions. Clinical trial results.
Divina Glah

IDrugs· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis